series-b
Stage
1
Investors
About
LabGenius Therapeutics develops therapeutic antibodies using an automated platform called EVA that applies machine learning to discover and optimize complex antibody molecules, focusing on selectivity-enhanced antibodies for treating solid tumors.
Explore LabGenius Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.